Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07225400 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment

Study acronym: SNav
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Study sites: 1 to 2
    • Start date: Oct 1, 2026 to Sep 15, 2026
    v5
  2. Start date: Aug 1, 2026 to Oct 1, 2026v4
  3. Start date: May 1, 2026 to Aug 1, 2026
    • Primary and study completion pushed from Aug 5, 2027 to Dec 23, 2027
    v3
  4. Start date: Mar 1, 2026 to May 1, 2026
    • Primary and study completion dates: Jun 5, 2027 to Aug 5, 2027
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this one-arm clinical trial is to determine whether participants with mild cognitive impairment (MCI) can successfully navigate a virtual reality (VR) maze. The VR maze is designed as a training tool aimed at improving participants' spatial navigation abilities. Main Aims: 1. To determine whether at least 70% of older adults enrolled in the study can complete twenty-four 50-minute training sessions over a 4-month period. 2. To assess whether combining virtual reality with EEG recordings can be used to measure brain activation and changes in brain activation associated with spatial navigation learning. Participants will: 1. Walk in an open, unobstructed space while wearing VR goggles. 2. Explore up to fifty different virtual mazes in sequence and attempt to find their way through each one.
Trial Details
NCT Number NCT07225400
Lead Sponsor Albert Einstein College of Medicine
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Mild Cognitive Impairment (MCI)
Related terms Cognitive Dysfunction
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov